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Abstract 
Background: The evidence base to assess the efficacy and effectiveness of alcohol brief interventions 
(ABI) is weakened by variation in the outcomes measured and by inconsistent reporting. The Outcome 
Reporting in Brief Intervention Trials: Alcohol (ORBITAL) project aims to develop a Core Outcome Set 
(COS) and reporting guidance for its use in future trials of ABI in a range of settings. 
Methods/Design: An international Special Interest Group was convened through INEBRIA 
(International Network on Brief Interventions for Alcohol and Other Drugs) to inform the development 
of a COS for trials of ABI. ORBITAL will incorporate a systematic review to map outcomes used in 
efficacy and effectiveness trials of ABI and their measurement properties, using the COnsensus-based 
Standards for the selection of health Measurement INstruments (COSMIN) criteria. This will support a 
multi-round Delphi study to prioritise outcomes. Delphi panellists will be drawn from a range of 
settings and stakeholder groups. A consensus meeting with key stakeholder representation will 
determine the final COS and associated guidance for its use in trials of ABI. 
Discussion: ORBITAL will develop a COS for alcohol screening and brief intervention trials, with 
outcomes stratified into domains and guidance on outcome measurement instruments. The 
standardization of ABI outcomes and their measurement will support the ongoing development of ABI 
studies and a systematic synthesis of emerging research findings. We will track the extent to which 
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the COS delivers on this promise through an exploration of the use of the guidance in the decade 
following COS publication.  
 
Keywords: Consensus methods, core outcome set, Delphi technique, screening, brief Intervention, 
alcohol, measurement, alcohol brief intervention, trial, outcomes standardization 
 
 
 
Background 
As early as the start of the WHO Collaborative Project on Detection and Management of Alcohol-
related Problems in Primary Health Care in the early 1980s (1), researchers have recognized a need to 
address alcohol problems across a wide spectrum of use levels, from hazardous use to dependence. 
Alcohol brief interventions (ABIs) have emerged as the main approach to addressing hazardous and 
harmful alcohol use in primary health care, beginning with the results of the DRAMS trial reported in 
1987 (2). However, ABIs can be used in a range of settings beyond primary care, such as emergency 
departments (3, 4), general hospital wards (5, 6), schools (7, 8), online (9, 10), criminal justice (11, 12), 
and workplaces (13, 14).  
ABIs vary in nature, ranging from very brief to more extended models and can be delivered in 
a variety of ways (15-17). For the research presented here, we use NICE guidance PH24 (18) on the 
prevention and early identification of alcohol-use disorders (including hazardous drinking, harmful 
drinking and alcohol  dependence) among adults and adolescents (aged 16+ years) to guide our 
definition of ABI. ABIs are defined as interventions suitable for those not seeking treatment for an 
alcohol problem but who are identified by screening as having, or being at risk of problems from their 
alcohol use. ABIs are behavioural interventions that aim to help someone reduce their alcohol 
consumption. They can consist of short, often single sessions of feedback and tailored advice (brief 
advice), or longer, motivationally-based interventions that explore motivations for drinking and 
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personal barriers to change (extended brief intervention).  PH24 recommends screening and brief 
intervention for people at risk of or experiencing harm from alcohol aged 16 and above who are not 
engaged in or seeking treatment for alcohol dependence or alcohol-related problems (19).  
Multiple systematic reviews and meta-analyses support the effectiveness of ABIs in reducing 
alcohol use in primary health care (20-22).  However, research on ABI is marked by conflicting findings 
regarding efficacy and effectiveness across primary health care, emergency services, hospitals, 
criminal justice, workplaces, online, and other settings (23-29).  An avoidable source of this conflict 
arises from the wide range of outcomes used to measure alcohol-related and other relevant change. 
The use of these different end points pose a challenge to combining data in meta-analysis to ascertain 
efficacy and effectiveness, and contribute to waste in research (30). The lack of consistency and 
standardization in outcomes also impedes the conduct of economic evaluations in alcohol research 
(31). The selection and application of well-designed outcomes by trial steering committees or other 
evaluation researchers (32) is relevant to all stakeholders, including service users, practitioners and 
policymakers. Optimised measurement of change will maximise the potential of ABI research to 
influence decision-making, as it has in other research areas such as rheumatoid arthritis (33, 34). 
Systematic reviews summarising the effectiveness of a wide range of health care interventions 
shows considerable heterogeneity in outcome measures used (35), and research has also highlighted 
the problem of selective and incomplete reporting (36) in Cochrane reviews. The same is true for 
reviews of ABI delivered in a variety of settings (20, 37-42). As such, it is difficult to compare findings 
of different research trials and other evaluations, even though they aim to address similar research 
questions. As replicability is essential to scientific progress (43), the use of different instruments 
measuring key outcomes in studies testing the same general hypotheses impedes progress in the ABI 
field. Furthermore, if we aim for improved change measurement, a reliance on statistical significance 
should be replaced by precise estimates of differences, which is again dependent on the use of 
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common measures to compare effect sizes. Meta-analysis is more accurate and informative when 
applied to a common metric rather than a generalised effect size convention (44). 
Both the Consolidated Standards of Reporting Trials (CONSORT) statement (45) and the 
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement (46) 
recommend the use of a core outcome set, and draw upon the COMET Initiative for guidance (35). 
Developing a standard way for authors to prepare and present trial findings ensures complete and 
transparent reporting, which is essential to critical appraisal and interpretation.  
 
At a workshop on “Design and conduct of randomised controlled trials of brief interventions 
for alcohol and drugs” at the INEBRIA conference in Warsaw in 2014, it was proposed to establish a 
Special Interest Group (SIG) to consider ways to standardise measures used in research on the efficacy 
and effectiveness of brief interventions. This proposal was approved by the INEBRIA Coordinating 
Committee, leading to the formation of the INEBRIA Research Measurement Standardisation Group 
and, later, the Outcome Reporting in Brief Intervention Trials (ORBITAL) group which, as of 2016, 
includes 29 members.  
Aims and research questions 
The primary aim of ORBITAL is to develop a COS for ABI efficacy and effectiveness trials. The secondary 
aim is to understand the variability in outcomes and measurement instruments in existing trials across 
all settings and to organise this information in the most efficient way for future trials of ABI in a 
published statement, the “ORBITAL statement”.  
The research questions are:  
1. What domains, outcomes, and instruments have been used in efficacy and effectiveness trials 
of Alcohol Brief Intervention? 
2. What outcomes are ranked by stakeholders as most important for the ORBITAL COS? 
3. What outcomes are relevant for different settings?  
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4. To what extent is the COS be used in the decade following its publication?  
 
Methods/Design 
The first step in developing this COS will be to review existing literature to identify outcomes organised 
by domain (“what to measure”) and instruments (“how to measure”). Instruments will be rated in 
terms of validity, reliability, responsiveness to change and usability in ABI settings, effectively 
summarising and mapping change measurement in the ABI field. The ratings will be based on the 
COSMIN criteria (47). This map of change measurement will be presented to stakeholders in the field, 
including patient and public representatives (PPR) and beneficiaries of ABI. For this study, PPR are 
advocates for those who are experiencing alcohol problems, hazardous or harmful drinkers, and those 
with prior experience of dependence, some of whom may have used an alcohol brief intervention in 
the past. This represents the range of end users of ABIs. Priority outcomes will be identified through 
Delphi consensus. The findings will be discussed and incorporated in the ORBITAL statement of 
reporting and measurement guidance on a COS organised into domains. Given the breadth of the 
settings in which ABIs are implemented, the structure and content of the final ORBITAL statement is 
yet to be determined since the COS might contain outcomes and instruments that are applicable 
across all settings and content areas, or there might be a core with a subset of outcomes and 
instruments unique to a single setting or to specific content areas. The Delphi study and consensus 
meeting will incorporate this decision-making element, and the decision-making process will be 
carefully documented and reviewed for potential bias.  
The methods of this project comprise five phases. Phase one consists of a systematic review 
to identify the outcomes and instruments (ranked by COSMIN criteria). Full details of this review can 
be found in PROSPERO (Registration number- CRD42016047185) and will not be discussed further 
here. The second to fifth phases, discussed below, are: (2) a Delphi study to rank the outcomes in 
priority order; (3) a consensus meeting to determine the final set and instruments; (4) reporting and 
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dissemination; and (5) an assessment of the utility of the COS in the decade following the publication 
of the ORBITAL COS statement.  
Phase 2: Delphi study  
To reduce the number of possible outcomes to a priority list for discussion at a consensus meeting, 
we will use the Delphi method. This is an iterative consensus technique which comprises sequential 
questionnaires answered anonymously by a range of relevant participants (48). We will seek input 
from an international and diverse stakeholder panel. A series of sequential questionnaires will be 
presented in ‘rounds’. The Delphi panel will comprise a range of stakeholders recruited from the 
following groups who will be contacted directly by email, with the suggestion to share the invitation 
to participate with their colleagues. The stakeholders (some of which overlap) include:  
• Trial investigators – First and last authors of reports of randomized trials in the field identified 
in the systematic review; 
• Members of the INEBRIA special interest group of the ORBITAL project (which includes 
researchers in brief interventions, methodologists, trialists, and health professionals); 
• Executive leadership of relevant scientific organizations such as the Research Society on 
Alcoholism, the Association for Medical Education and Research in Substance Abuse, the 
Society for the Study of Addiction to Alcohol & Other Drugs, and the College on Problems of 
Drug Dependence;  
• Cochrane Review Group on Drugs and Alcohol; 
• NICE Alcohol-use Disorders: Prevention PH24 membership group;  
• People listed as being involved in ABI clinical guidance including through the World Health 
Organization (WHO), the US Centers for Disease Control and Prevention (CDC), the US 
Substance Abuse and Mental Health Services Administration (SAMHSA), the US National 
Institutes of Health (NIH), and the National Board of Health and Welfare (Sweden); 
• Research funders acknowledged as funding the ABI studies included in the review; 
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• Journal editors and the Editorial Boards of journals who are members of the International 
Society of Addiction Journal Editors; 
• ABI academics who have experience of being on Research Ethics Committees; 
• Statisticians, trialists, and COS developers; 
• Service users and service user representatives; 
• Practitioners: including representatives from health, education, alcohol and drug services, 
criminal justice and workplace health. 
Panel size and recruitment  
There are no accepted guidelines for panel size to achieve stable consensus in a Delphi analysis. Like 
others (49), we will be guided by practicality, scope and time available. We will aim to recruit and 
retain as large a panel as possible. Participants will be invited to nominate others to contribute 
(snowball sampling). Individuals will be identified through a range of contacts by ORBITAL team 
members, including INEBRIA members. The Project Manager (GS) and other members of the steering 
group will invite participants from international stakeholder groups, using distribution lists such as 
Addict-L, Addiction Medicine, Drug Misuse Research, BALANCE, Alcohol Misuse (Scottish Addiction 
Studies), Drugtalk, Ewodor, and Kettil Bruun Society. Other key methodologists will be reached 
through the UK Hubs for Trials Methodology Research and Clinical Trials Units in the UK. We will also 
recruit Delphi panellists from the WHO Department of Mental Health and Substance Abuse and from 
the US NIH, CDC, and SAMHSA.  
We aim to complete the Delphi analysis after two rounds. However, if deemed necessary by 
the ORBITAL steering group because of a clear lack of consensus we will have a third round. We will 
reduce attrition between rounds through the following techniques: a personalised invitation, outline 
of timelines, personalised email reminders (every two weeks, but with no more than four reminders), 
and provision of an easy interface which minimises the time required to complete each round (49). 
We will use online COMET software designed specifically for the purposes of conducting Delphi studies 
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to generate COS. The importance of completing all rounds will be emphasised to participants in the 
information sheet. 
The Delphi questionnaire and rounds 
In round one, participants will be asked to rate each outcome using a scale of 1-9, with 1-3 labelled 
‘not important for inclusion’, 4-6 labelled ‘important but not critical’ and 7-9 labelled ‘critical for 
inclusion’ (49). The outcomes will be generated from the systematic review in Phase 1. Outcomes will 
be listed randomly, and hosted on COMET software (DelphiManager), to avoid leading participants to 
believe some are more important than others. PPR will be consulted in the presentation and 
explanation of the outcomes. Participants also have the opportunity to add additional outcomes and 
to comment on why they have ranked outcomes as they have. Novel outcomes will be reviewed and 
coded by at least two reviewers to determine if they are indeed novel and cannot be subsumed into 
existing outcomes; where there is disagreement, an additional reviewer will be consulted. 
All outcomes will be carried through to the second round with first round scores displayed for 
each outcome calculated as a percentage of responses split by respondent group. Consensus is defined 
a priori as 70% or more of the respondents scoring an outcome from 7 to 9 and fewer than 15% scoring 
it 1 to 3, in line with similar studies (48-51). All other score distributions would be taken to indicate 
lack of agreement for inclusion of a given outcome in the COS. The rationale for this threshold reflects 
an outcome agreed by the majority as critically important, with only a small minority ranking an 
outcome as being of little or no importance. Likewise, consensus that an outcome should not be in 
the COS requires agreement by the majority that the outcome is of little or no importance, with no 
more than a small minority considering it to be critically important. We recognise that choice of 
thresholds is somewhat subjective, but specification of the definition in a study protocol reduces the 
risk that researchers will define consensus post hoc in a way that would bias the conclusions toward 
their own beliefs (35).  
Ethical considerations 
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Ethics approval will be sought from Teesside University Ethics Committee to conduct the Delphi 
study. Informed consent will be sought from all participants. Individual participants will be 
approached or will volunteer themselves by the methods outlined above. They will be sent a short 
email introducing the study, with more information on the study and consent forms available online. 
Information on the composition of the Delphi panel will be collated, including age, background, 
experience in years, field of interest, and current working location. Participants in the Delphi panel 
who agree to be named will be listed in alphabetical order online, and participants who request it 
will be emailed the final ORBITAL statement. 
Phase 3: Consensus meeting 
After the Delphi study is completed, a convenience sample of representatives of the stakeholder 
groups will be invited to join a consensus meeting to determine the final COS. We will aim to include 
at least one person from each stakeholder group, and understand that there may be overlap. This is 
in keeping with guidance from Tugwell et al. (30) and Prinsen et al.  (34, 52). The consensus meeting 
will be recorded to evidence decision making. The meeting minutes will be available, and a summary 
report will be published. The results of the Delphi study on what to measure will be discussed at the 
consensus meeting and representatives will be asked to discuss ‘how’ the outcome variables in the 
COS should be measured. If the number of outcomes prioritised in the Delphi study is too large to 
allow time to discuss the measurement of the COS items during the main consensus meeting, a 
separate consensus meeting may be held by teleconference to consider the COSMIN rankings of each 
measure under each outcome. Given the number of domains will be unknown until the Delphi is 
complete, a second Delphi may also be proposed to rank the ‘how’ to measure under each of the 
domains in the event that a) there is limited evidence to support ‘how’ to measure domains, or b) 
there are too many measures under each domain to discuss at a consensus meeting. Should this be 
required, a separate protocol will be generated, and a separate ethics application sought from 
Teesside University Ethics Committee. The editors from key addiction journals will be invited to discuss 
how best to use and disseminate the COS. 
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Phase 4: Reporting and dissemination 
The protocol for the ORBITAL COS has been registered on the COMET Initiative website to prevent 
unnecessary duplication of effort. Several subsequent ORBITAL publications are planned, including the 
results of the systematic review to identify what outcomes to measure and the COSMIN ranking of 
how to measure them. The Delphi study will also be written up for publication, noting the changes to 
the list of outcomes suggested at each stage. The consensus meeting will be documented and a 
manuscript written describing any decision-making challenges and how these were overcome. The 
final COS will be reported in the context of the COS-STAR guidance (53).  
Phase 5: Assessment of the uptake of the COS in future trials 
Subject to funding, regular checks on how the COS is used over the subsequent decade will be carried 
out using Google Scholar and Scopus. Alerts will be set up to notify the team when the COS is cited 
and annual updates will be reported to the INEBRIA Coordinating Committee and the INEBRIA general 
membership at the annual conference and via the INEBRIA Google Group.  
Discussion 
This protocol describes a programme of work to develop a core outcome set for assessing the efficacy 
and effectiveness of alcohol brief intervention in clinical trials across all settings. The scope for the 
core outcome set is deliberately broad, given the wide variety of locations and types of alcohol brief 
intervention. This in itself is a challenge, and the nature of the core outcome set will depend greatly 
on the findings of the systematic review. To the best of our knowledge, this will be the first Delphi 
study to ask for comment on the suitability of outcomes across such a wide range of settings, and to 
raise the possibility of having a COS which is based around a core subset with some sub-core aspects 
depending on the setting or nature of the brief intervention. As such, the decision-making process in 
developing the COS will need to be clear on how and why decisions were made and by whom [48]. 
Other innovative features of this protocol include the plan to follow up on the utility and use of the 
COS and an a priori recognition that technological developments and changes in healthcare worldwide 
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will make it important to revisit the COS periodically, assessing its continued utility for the 
contemporary alcohol brief intervention field.  
Study status 
As of April 2017, the systematic review (Prospero registration number: - CRD42016047185) has 
started. The Delphi study has not yet begun, and a list of potential participants is being collated.  
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